Resources | Beta Cells in Diabetes

ResourcesResources RSS

Resource Library

View the Full Resource List

Search Resources

Hypoglycemia and diabetes: a report of a workgroup of the american diabetes association and the endocrine society.

Seaquist, Elizabeth R; Anderson, John; Childs, Belinda; Cryer, Philip; Dagogo-Jack, Samuel; Fish, Lisa; Heller, Simon R; Rodriguez, Henry; Rosenzweig, James; Vigersky, Robert

Diabetes care; 2013 May;36(5):1384-95. PMID: 23589542;

Category: General Reviews;

Tags: beta cell pathophysiology, glycemic control, insulin therapy, sulfonylureas (SUs), weight
The Prevalence of Meeting A1C, Blood Pressure, and LDL Goals Among People With Diabetes, 1988-2010.

Stark Casagrande, Sarah; Fradkin, Judith E; Saydah, Sharon H; Rust, Keith F; Cowie, Catherine C

Diabetes care; 2013 Feb 15 PMID: 23418368;

Category: General Reviews;

Tags: glycemic control
Year in Diabetes 2012: The Diabetes Tsunami

R. Sherwin and A. M. Jastreboff

Journal of Clinical Endocrinology and Metabolism

Category: General Reviews;

Tags: beta cell pathophysiology, DPP-4 inhibitors, GLP-1 agonists, glycemic control, insulin therapy, lifestyle changes, metformin, prediabetes, sulfonylureas (SUs), thiazolidinediones (TZDs), weight
Comparative effectiveness of sulfonylurea and metformin monotherapy on cardiovascular events in type 2 diabetes mellitus: a cohort study.

Roumie, Christianne L; Hung, Adriana M; Greevy, Robert A; Grijalva, Carlos G; Liu, Xulei; Murff, Harvey J; Elasy, Tom A; Griffin, Marie R

Annals of internal medicine; 2012 Nov 6;157(9):601-10. PMID: 23128859;

Category: General Reviews;
Systematic review of SGLT2 receptor inhibitors in dual or triple therapy in type 2 diabetes.

Clar, Christine; Gill, James Alexander; Court, Rachel; Waugh, Norman

BMJ open; 2012;2(5) PMID: 23087012;

Category: Interventions;

Tags: SGLT-2 inhibitors
SGLT2 inhibition in diabetes mellitus: rationale and clinical prospects.

Ferrannini, Ele; Solini, Anna

Nature reviews. Endocrinology; 2012 Aug;8(8):495-502. PMID: 22310849;

Category: General Reviews;

Tags: SGLT-2 inhibitors
Sequential intensification of metformin treatment in type 2 diabetes with liraglutide followed by randomized addition of basal insulin prompted by A1C targets.

DeVries, J Hans; Bain, Stephen C; Rodbard, Helena W; Seufert, Jochen; D'Alessio, David; Thomsen, Anne B; Zychma, Marcin; Rosenstock, Julio

Diabetes care; 2012 Jul;35(7):1446-54. PMID: 22584132;

Category: General Reviews;

Tags: beta cell pathophysiology, DPP-4 inhibitors, GLP-1 agonists, glycemic control, insulin therapy, prediabetes
Sequential intensification of metformin treatment in type 2 diabetes with liraglutide followed by randomized addition of basal insulin prompted by A1C targets.

DeVries, J Hans; Bain, Stephen C; Rodbard, Helena W; Seufert, Jochen; D'Alessio, David; Thomsen, Anne B; Zychma, Marcin; Rosenstock, Julio

Diabetes care; 2012 Jul;35(7):1446-54. PMID: 22584132;

Category: Interventions;

Tags: GLP-1 agonists, glycemic control, insulin therapy, metformin, prediabetes
Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).

Inzucchi, Silvio E; Bergenstal, Richard M; Buse, John B; Diamant, Michaela; Ferrannini, Ele; Nauck, Michael; Peters, Anne L; Tsapas, Apostolos; Wender, Richard; Matthews, David R

Diabetes care; 2012 Jun;35(6):1364-79. PMID: 22517736;

Category: Additional Resources / Guidelines;

Tags: beta cell pathophysiology, DPP-4 inhibitors, GLP-1 agonists, glycemic control, insulin therapy, lifestyle changes, metformin, prediabetes
Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).

Inzucchi, Silvio E; Bergenstal, Richard M; Buse, John B; Diamant, Michaela; Ferrannini, Ele; Nauck, Michael; Peters, Anne L; Tsapas, Apostolos; Wender, Richard; Matthews, David R

Diabetes care; 2012 Jun;35(6):1364-79. PMID: 22517736;

Category: Additional Resources / Guidelines;

Tags: beta cell pathophysiology, DPP-4 inhibitors, GLP-1 agonists, glycemic control, insulin therapy, lifestyle changes, metformin, prediabetes, sulfonylureas (SUs), thiazolidinediones (TZDs), weight